- Stage
- In committee
- Started in
- House
- Sponsors
- 6
- Latest action
- Sep 18, 2025
What it does
The PAAT Act would require Medicare Part D prescription drug plans to cover drugs used to treat autoimmune diseases, hemophilia, and Von Willebrand disease starting in 2027. It would also prohibit plans from requiring prior authorization for these drugs more than once per year, with limited exceptions. The bill affects Medicare beneficiaries who rely on these treatments and the private plans that administer Part D coverage.
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.